Sandy Macrae

Insider Reports History

Entity
Individual
Location
721 St. Georges Road, Philadelphia, PA
Signature
/s/ Ron A. Metzger, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sandy Macrae:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SANGAMO THERAPEUTICS, INC PRESIDENT, CEO AND DIRECTOR, Director Common Stock 2.51M $4.87M $1.94 Nov 25, 2024 Direct

Insider Reports Filed by Sandy Macrae

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SGMO SANGAMO THERAPEUTICS, INC Nov 24, 2024 2 -$34.7K 4 Nov 26, 2024 PRESIDENT, CEO AND DIRECTOR, Director
SGMO SANGAMO THERAPEUTICS, INC Aug 24, 2024 2 -$11K 4 Aug 27, 2024 PRESIDENT, CEO AND DIRECTOR, Director
SGMO SANGAMO THERAPEUTICS, INC May 24, 2024 2 -$7.65K 4 May 29, 2024 PRESIDENT, CEO AND DIRECTOR, Director
SGMO SANGAMO THERAPEUTICS, INC Feb 24, 2024 2 -$45.5K 4 Feb 27, 2024 PRESIDENT, CEO AND DIRECTOR, Director
SGMO SANGAMO THERAPEUTICS, INC Jan 22, 2024 1 $0 4 Jan 24, 2024 PRESIDENT, CEO AND DIRECTOR, Director
SGMO SANGAMO THERAPEUTICS, INC Nov 25, 2023 1 -$3.98K 4 Nov 28, 2023 President, CEO and Director, Director
SGMO SANGAMO THERAPEUTICS, INC Aug 25, 2023 1 -$8.02K 4 Aug 29, 2023 President, CEO and Director, Director
SGMO SANGAMO THERAPEUTICS, INC May 25, 2023 1 -$13.8K 4 May 30, 2023 President, CEO and Director, Director
SGMO SANGAMO THERAPEUTICS, INC Feb 24, 2023 3 -$146K 4 Mar 6, 2023 President, CEO and Director, Director
SGMO SANGAMO THERAPEUTICS, INC Feb 25, 2022 3 -$294K 4 Mar 1, 2022 President, CEO and Director, Director